dc.contributor.author | Omorphos, Nicolas | |
dc.contributor.author | Pansaon Piedad, John Carlo | |
dc.contributor.author | Vasdev, Nikhil | |
dc.date.accessioned | 2020-09-30T00:34:17Z | |
dc.date.available | 2020-09-30T00:34:17Z | |
dc.date.issued | 2020-09-21 | |
dc.identifier.citation | Omorphos , N , Pansaon Piedad , J C & Vasdev , N 2020 , ' Guideline of Guidelines: Muscle Invasive Bladder Cancer ' , Turkish Journal of Urology . https://doi.org/10.5152/tud.2020.20337 | |
dc.identifier.issn | 2149-3057 | |
dc.identifier.other | PURE: 22541327 | |
dc.identifier.other | PURE UUID: 9f14467d-4227-48cb-be65-b6edac1a6b52 | |
dc.identifier.other | Scopus: 85101565436 | |
dc.identifier.uri | http://hdl.handle.net/2299/23193 | |
dc.description | © 2020 Turkish Society of Urology. Final publication available at https://dx.doi.org/10.5152/tud.2020.20337. | |
dc.description.abstract | Muscle-invasive bladder cancer accounts for 25% of bladder cancer cases and represents a spectrum of disease, which can result in significant morbidity and mortality for anyone affected. Current management has evolved through years of research and clinical practice. It is based on a risk-benefit approach, which is often tailored to the individual requirements of patients and involves cystectomy, neoadjuvant and adjuvant therapies, and multimodal surveillance paradigms to achieve high survival rates. Multiple guidelines exist to assist the clinicians in this decision-making process, but their adherence is often variable. In this article, we aimed to review the 4 most commonly used guidelines from the European Association of Urology, the National Institute for Health and Care Excellence, the National Comprehensive Cancer Network, and the American Urological Association. | en |
dc.format.extent | 8 | |
dc.language.iso | eng | |
dc.relation.ispartof | Turkish Journal of Urology | |
dc.title | Guideline of Guidelines: Muscle Invasive Bladder Cancer | en |
dc.contributor.institution | Department of Clinical and Pharmaceutical Sciences | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.contributor.institution | Basic and Clinical Science Unit | |
dc.contributor.institution | Extracellular Vesicle Research Unit | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.description.status | Peer reviewed | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | https://doi.org/10.5152/tud.2020.20337 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |